Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Psychotherapy for Alcohol Use Disorder
NCT04158778Phase 1Unknown
- Sponsor
- Imperial College London
- Start
- Apr 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of midomafetamine in alcohol use disorder (AUD), sponsored by Imperial College London. Primary endpoint: Safety and tolerability as measured by adverse event at 8 weeks. Status: unknown.
02
Drugs
midomafetamine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04158778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158778.